 BNP Paribas Arbitrage SA grew its stake in Atara Biotherapeutics Inc NASDAQ:ATRA by 330.3 during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,553 shares of the biotechnology companys stock after purchasing an additional 21,150 shares during the period. BNP Paribas ... 